BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
Rhea-AI Summary
Bio-Techne (NASDAQ: TECH) has announced its participation in three upcoming investor conferences in November 2024. The company will present at the UBS Global Healthcare Conference on November 12 at 9:30 AM PST, the Stifel 2024 Healthcare Conference on November 19 at 8:00 AM EST, and the Stephens NASH 2024 Conference on November 20 at 11:00 AM CST. Interested parties can access live webcasts of all presentations through Bio-Techne's Investor Relations website's IR Calendar page.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, TECH declined 0.60%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
UBS Global Healthcare Conference
November 12, 2024
9:30 AM PST
Stifel 2024 Healthcare Conference
November 19, 2024
8:00 AM EST
Stephens NASH 2024 Conference
November 20, 2024
11:00 AM CST
A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately
Contact: | David Clair, Vice President, Investor Relations & Corporate Development |
612-656-4416 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-investor-conferences-302298610.html
SOURCE Bio-Techne Corporation
